Benzinga · Jun 26, 2026
Acadia Pharma Stock Jumps After European Panel Reverses Course On Rett Syndrome Therapy
Acadia shares rise after CHMP recommends DAYBU for Rett syndrome in the European Union, reversing an earlier negative opinion.
AMEX · AWEG
Alger Weatherbie Enduring Growth ETF
Financial Services · Asset Management
$22.55
Down-$0.01 (-0.04%)
Updated Aug 31, 2026, 9:33 PM
SID Score
4.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 5.26M
- P/E ratio
- —
- Dividend yield
- 3.81%
- 52-week range
- $20.61 – $24.94
- Volume
- 21
- Avg. volume
- 407
Price performance
AWEG price history
1M range · 0 trading sessions · Daily adjusted prices
AWEG does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest AWEG news
The latest Smart Investors Daily articles mentioning AWEG.
Stock researchCompany · Overview
AWEG research
Overview
Company profile and research snapshot.
Company profile
The fund invests primarily in equity securities of mid-cap growth companies with an environmental, social and governance (“ESG”) rating of medium or better, as rated by Sustainalytics, a third-party ESG rating agency, at the time of purchase. Under normal circumstances, 80% of companies in the fund’s portfolio, based on net assets, will have a Sustainalytics ESG rating. The fund is non-diversified.
Analyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
